Kidney Cancer Diagnostics Market Sales Revenue To Substantially Surge In Next Ten Years 

Key Segments Covered



End User

Key Takeaways from Market Study

– Global kidney cancer diagnostics market to top US$ 1.2 Bn by 2031. – Immunochemistry tests projected to reach around US$ 550 Mn by 2031. – Urine tests projected to record above 5% CAGR over next 10 years. – Market in North America holds share of more than 50%. – Market in South Korea expected to reach valuation of US$ 350 Mn by 2031. – Market in Australia to record 4% CAGR over forecast period of 2021- 2031.

Key Companies Profiled

– Myriad Genetics Inc. – NeoGenomics Laboratories – NanoString Technologies Inc. – Sysmex Corporation – Rosetta Genomics – Illumina Inc. – Quest Diagnostics Incorporated – Roche Holding AG – Thermo Fisher Scientific Inc. – Abbott Laboratories

Explore Fact.MR Comprehensive Coverage Healthcare Market